SIGY — Sigyn Therapeutics, Inc.
—
OTC ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1642159 ·
Last close
—
Market Cap
—
52W High
—
52W Low
—
ADV30
—
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2025 | 0 | 0 | -386,529 | -578,503 | 135,571 | 85,571 | 6,052,780 |
| Jun 2025 | 0 | 0 | -469,513 | -1,451,187 | 51,759 | 459 | 5,489,388 |
| Mar 2025 | 0 | 0 | -546,059 | -668,564 | 244,309 | 12,895 | 5,189,516 |
| Dec 2024 | 0 | 0 | -478,010 | -522,818 | 213,719 | 12,144 | 4,671,343 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-936,426
Investing CF
$0
Financing CF
$857,209
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-1.68
As of
2026-08-09
Balance + Analyst (yfinance extras)
Retained Earnings
$-17,379,978
Inventory
$0
Receivables
—
ST Investments
—
EBIT TTM
$-2,674,005
Pretax Income TTM
$-3,221,072
Interest Exp TTM
$547,067
Analysts
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2024 | 0 | -2,519,242 | -3,340,212 | 213,719 | 4,671,343 | -4,457,624 | -872,436 |
| Dec 2023 | 0 | -2,455,317 | -4,145,936 | 321,806 | 3,734,306 | -3,412,500 | -1,383,210 |
| Dec 2022 | 0 | -2,147,265 | -2,929,817 | 332,879 | 2,236,119 | -1,903,240 | -1,830,242 |
| Dec 2021 | 0 | -2,008,217 | -3,004,619 | 710,259 | 974,843 | -264,584 | -1,774,182 |
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| ISRG | INTUITIVE SURGICAL INC | $145.17B | $405.18 | — |
| MDT | Medtronic plc | $113.38B | $88.64 | — |
| SYK | STRYKER CORP | $104.47B | $272.36 | — |
| MMM | 3M CO | $87.44B | $169.55 | — |
| BSX | BOSTON SCIENTIFIC CORP | $63.65B | $43.92 | — |
News headlines (Yahoo Finance, 1h cache)
Oragenics Signs Letter of Intent to License CardioDialysis™ Technology from Sigyn Therapeutics to Target TBI-Induced Systemic Inflammation
2026-05-07 12:30 · Yahoo
Q2 Virtual Investor Summit Presentations Now Available On Demand
2026-06-30 17:20 · Yahoo
Sigyn Therapeutics Launches Initiative to Evaluate Emerging Medical Technologies in Former NFL Players at Risk of CTE
2026-04-02 11:47 · Yahoo
CardioDialysisTM, a Next-Generation Technology to Reduce Major Adverse Cardiovascular Events
2026-03-27 14:09 · Yahoo
Scientific American Highlights Scientific Discovery That Supports the Potential Use of CardioDialysis(TM) to Treat Neuroinflammatory Diseases
2026-03-24 11:47 · Yahoo
Sigyn Therapeutics Issues Shareholder Update Regarding Potential Merger and Asset Sale Initiatives
2026-03-13 16:02 · Yahoo
Sigyn Therapeutics Issues Shareholder Update Highlighting the Advancement of CardioDialysis(TM) and New Corporate Initiatives
2026-01-15 15:44 · Yahoo
The Emergence of Blood Purification Devices to Treat Cardiovascular Disease
2026-01-06 21:51 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.